Taysha Gene Therapies
Megan (Guadagnino) Venn has a diverse work experience in the biotech and pharmaceutical industry. Megan is currently working at Taysha Gene Therapies as a Senior Specialist III in External Quality Operations. Prior to this, they served as a Lead Specialist in QC Sample Control at bluebird bio. Megan also has experience at Johnson & Johnson as a Senior Analyst in QC CAR-T, at Astoria-Pacific, Inc. as an Applications Scientist, at bioMérieux as an Associate Scientist, and at North Carolina State University as an Undergraduate Researcher. Megan'sroles have spanned various responsibilities and positions within the industry.
Megan (Guadagnino) Venn obtained their Master of Science (MS) degree in Management and Leadership from Western Governors University in 2017-2018. Prior to that, they completed their Bachelor of Science (B.S.) degree in Botany/Plant Biology at North Carolina State University from 2012 to 2015. Additionally, in 2011-2012, they attended Millersville University of Pennsylvania, although the degree and field of study for that period are unspecified. Furthermore, Megan obtained another Master's degree in Management and Leadership from Western Governors University, completing it in 2018.
This person is not in any offices
Taysha Gene Therapies
Taysha Gene Therapies is on a mission to eradicate severe and life-threatening monogenic CNS disease. With a singular focus on developing curative medicines, they hope to rapidly translate their treatments from bench to bedside.